Literature DB >> 23090037

The incidence of primary antibiotic resistance of Helicobacter pylori in Vietnam.

Tran T Binh1, Seiji Shiota, Lam T Nguyen, Dung D Q Ho, Hai H Hoang, Long Ta, Dung T Trinh, Toshio Fujioka, Yoshio Yamaoka.   

Abstract

GOALS: To determine the susceptibility of Helicobacter pylori strains isolated from a Vietnamese population to 5 antibiotics.
BACKGROUND: The incidence of antibiotic resistance in H. pylori infection is increasing worldwide and has become a leading cause for failure of treatment. Antibiotic susceptibility testing is very important to provide optimal regimens in a clinical setting. STUDY: We isolated 103 H. pylori strains from the gastric mucosa of H. pylori-infected patients from 2 areas in Vietnam (Ho Chi Minh and Hanoi) in 2008. Epsilometer test was used to determine the minimum inhibitory concentrations of amoxicillin, clarithromycin (CLR), metronidazole (MNZ), levofloxacin, and tetracycline.
RESULTS: Among the 103 strains, the resistance rates were 0% (amoxicillin), 33% (CLR), 69.9% (MNZ), 18.4% (levofloxacin), and 5.8% (tetracycline). The resistant strains showed a high-level of resistance (≥ 256 µg/mL) to CLR, 23.5% (8/34), and MNZ, 29.1% (21/72). The resistance rate for CLR was significantly higher in Ho Chi Minh than in Hanoi (49% vs. 18.5%, P=0.001). Resistance to both CLR and MNZ was most commonly observed (24.3%). Two strains (1.9%) were resistant to 4 of the 5 antibiotics. No significant association was observed between antibiotic resistance rates and age, sex, or clinical outcomes of the patients.
CONCLUSIONS: High incidence of resistance to CLR and MNZ suggests that standard triple therapies may not be useful as first-line treatment in Vietnam. Alternative strategies such as bismuth-based quadruple therapies or sequential therapy may be more effective in Vietnam.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23090037      PMCID: PMC3556356          DOI: 10.1097/MCG.0b013e3182676e2b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  55 in total

Review 1.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years.

Authors:  Seiichi Kato; Shigeru Fujimura
Journal:  Pediatr Int       Date:  2009-06-26       Impact factor: 1.524

Review 4.  Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori.

Authors:  F Mégraud
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

5.  Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.

Authors:  Y J Debets-Ossenkopp; A J Herscheid; R G Pot; E J Kuipers; J G Kusters; C M Vandenbroucke-Grauls
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

Review 6.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

7.  Antibiotic susceptibility of Helicobacter pylori in the Chinese population.

Authors:  J Yakoob; X Fan; G Hu; L Liu; Z Zhang
Journal:  J Gastroenterol Hepatol       Date:  2001-09       Impact factor: 4.029

8.  Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.

Authors:  Hong Sang Oh; Dong Ho Lee; Ji Yeon Seo; Yu Ri Cho; Nayoung Kim; Sook Hyang Jeoung; Jin Wook Kim; Jin Hyeok Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin; Hyun Jin Cho; Hyun Chae Jung; In Sung Song
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

9.  Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up.

Authors:  Lucy Vannella; Edith Lahner; Cesare Bordi; Emanuela Pilozzi; Emilio Di Giulio; Vito D Corleto; John Osborn; Gianfranco Delle Fave; Bruno Annibale
Journal:  Dig Liver Dis       Date:  2010-11-27       Impact factor: 4.088

10.  Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.

Authors:  S W Hosking; T K Ling; S C Chung; M Y Yung; A F Cheng; J J Sung; A K Li
Journal:  Lancet       Date:  1994-02-26       Impact factor: 79.321

View more
  19 in total

1.  Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing.

Authors:  Tran Thanh Binh; Rumiko Suzuki; Tran Thi Huyen Trang; Dong Hyeon Kwon; Yoshio Yamaoka
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.

Authors:  Li-Juan Zhao; Yan-Qiang Huang; Bing-Pu Chen; Xiao-Qiang Mo; Zan-Song Huang; Xiao-Feng Huang; Lian-Deng Wei; Hong-Yu Wei; Yuan-Hong Chen; Hua-Ying Tang; Gan-Rong Huang; Yan-Chun Qin; Xiao-Hua Li; Lu-Yao Wang
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 3.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 4.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

Authors:  Reza Ghotaslou; Hamed Ebrahimzadeh Leylabadlo; Yalda Mohammadzadeh Asl
Journal:  World J Methodol       Date:  2015-09-26

Review 5.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 6.  Antibiotic treatment for Helicobacter pylori: Is the end coming?

Authors:  Su Young Kim; Duck Joo Choi; Jun-Won Chung
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

7.  The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.

Authors:  Jyh-Ming Liou; Chi-Yang Chang; Mei-Jyh Chen; Chieh-Chang Chen; Yu-Jen Fang; Ji-Yuh Lee; Jeng-Yih Wu; Jiing-Chyuan Luo; Tai-Cherng Liou; Wen-Hsiung Chang; Cheng-Hao Tseng; Chun-Ying Wu; Tsung-Hua Yang; Chun-Chao Chang; Hsiu-Po Wang; Bor-Shyang Sheu; Jaw-Town Lin; Ming-Jong Bair; Ming-Shiang Wu
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

8.  Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam.

Authors:  Camelia Quek; Son T Pham; Kieu T Tran; Binh T Pham; Loc V Huynh; Ngan B L Luu; Thao K T Le; Kelly Quek; Van H Pham
Journal:  F1000Res       Date:  2016-04-13

9.  Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur.

Authors:  Xinsheng Teh; Yalda Khosravi; Woon Ching Lee; Alex Hwong Ruey Leow; Mun Fai Loke; Jamuna Vadivelu; Khean Lee Goh
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

Review 10.  Quinolone-containing therapies in the eradication of Helicobacter pylori.

Authors:  Seng-Kee Chuah; Wei-Chen Tai; Chen-Hsiang Lee; Chih-Ming Liang; Tsung-Hui Hu
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.